NTC grants license and distribution rights in Mexico to Laboratorios Grin S.A. de C.V

  • Apr 21, 2020

Milan, April 21, 2020 – NTC Srl, an R&D focused pharmaceutical company headquartered in Italy, has granted license and distribution rights on one of its research and development products, a fixed combination in eye drops, in Mexico to Laboratorios Grin S.A. de C.V, a wholly owned affiliate of Lupin, focused on developing, manufacturing and distributing world-class medicines and a leader in the Ophthalmology segment. 

A three day intensive Action Agenda for NTC at CPhI 2019

  • Nov 5/7, 2019

CPhIWW represents for NTC an important event to create valuable long term business with partners from all over the world.

NTC at CPhI - Frankfurt 2019 - Stand 91B71

  • Nov 05, 2019

CPhI Worldwide, 5-7 November 2019.
See you in Frankfurt.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. READ MORE